MariMed (MRMD) Stock Price, News & Analysis

Company Overview

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Key Stats

• Today's Range: $0.10 to $0.12
• 50-Day Range: $0.08 to $0.14
• 52-Week Range: $0.07 to $0.34
• Volume: 481,784 shs
• Average Volume: 399,765 shs
• Market Capitalization: $41.20 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

MRMD Stock Analysis - Frequently Asked Questions

How have MRMD shares performed this year?

MariMed's stock was trading at $0.1158 at the start of the year. Since then, MRMD stock has decreased by 6.7% and is now trading at $0.1080.
View the best growth stocks for 2025 here.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) released its quarterly earnings results on Wednesday, March, 5th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The company earned $39 million during the quarter, compared to the consensus estimate of $42 million. MariMed had a negative net margin of 10.97% and a negative trailing twelve-month return on equity of 2.75%.
Read the conference call transcript.

How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MariMed own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include Canopy Growth (CGC), Innovative Industrial Properties (IIPR), NVIDIA (NVDA), Curaleaf (CURLF), Aurora Cannabis (ACB), Meta Platforms (META) and Tilray (TLRY).

Company Calendar

• Last Earnings: 3/05/2025
• Today: 4/25/2025
• Next Earnings (Estimated): 5/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:MRMD
• CIK: 1522767
• Web: marimedadvisors.com
• Phone: (617) 795-5140
• Fax: N/A
• Employees: 260
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-16,030,000.00
• Net Margins: -10.97%
• Pretax Margin: -5.28%
• Return on Equity: -2.75%
• Return on Assets: -1.06%

Debt

• Debt-to-Equity Ratio: 1.01
• Current Ratio: 1.55
• Quick Ratio: 0.73

Sales & Book Value

• Annual Sales: $148.60 million
• Price / Sales: 0.28
• Cash Flow: $0.02 per share
• Price / Cash Flow: 5.59
• Book Value: $0.19 per share
• Price / Book: 0.57

Miscellaneous

• Outstanding Shares: 381,489,000
• Free Float: 301,649,000
• Market Cap: $41.20 million
• Optionable: Not Optionable
• Beta: 2.75